OOIR: Observatory of International Research

Papers

(The median citation count of European Neuropsychopharmacology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Route map for machine learning in psychiatry: Absence of bias, reproducibility, and utility	353
P.0012 The costs of alcohol hangover for the Dutch economy: impact of absenteeism and presenteeism	104
T58. EXPLORATION OF GENETIC AND CLINICAL HETEROGENEITY IN AUTISM BY CLUSTERING GENES BASED ON BULK AND SINGLE-CELL TRANSCRIPTOMIC DATA	93
Stress, mental disorder and ketamine as a novel, rapid acting treatment	91
F75. PREDICTION OF TREATMENT-RESISTANT SCHIZOPHRENIA USING REAL-WORLD DATA AND MULTIMODAL ANALYTICAL TOOLS	82
41. CHARACTERIZING FUNCTIONAL CONVERGENCE OF COMMON POLYGENIC VARIATION IN NEUROPSYCHIATRIC DISORDER RISK GENES	69
F7. THE ASSOCIATIONS BETWEEN EDUCATIONAL EXPERIENCES AND MENTAL HEALTH FROM CHILDHOOD TO YOUNG ADULTHOOD	69
F48. INVESTIGATING POTENTIAL RELATIONSHIPS BETWEEN PIGMENTATION GENETICS AND PARKINSON'S DISEASE (PD)	67
F94. SIGNIFICANT TELOMERE SHORTENING IN MALAYSIAN PATIENTS WITH SCHIZOPHRENIA: RELATIONSHIP WITH TOTAL ANTIOXIDANT CAPACITY AND OTHER COVARIATES	62
83. DAMAGING RARE CODING VARIANTS IDENTIFIED BY EXOME SEQUENCING ARE ASSOCIATED WITH REDUCED COGNITIVE FUNCTION IN SCHIZOPHRENIA	62
HOW PARTICIPATING IN CAMH'S PHARMACOGENETICS IMPACT STUDY CHANGED MY LIFE	58
GENETIC COUNSELING FOR PSYCHIATRIC CONDITIONS	56
85. DETECTION OF PLACENTAL SCHIZOPHRENIA RISK GENES	52
37. CONVERGENT IMPACT OF SCHIZOPHRENIA RISK GENES	52
8. A CROSS-POPULATION GENOME-WIDE ASSOCIATION STUDY OF SLEEP DURATION	51
6. DE NOVO MUTATIONS IN BIPOLAR DISORDER IMPLICATE GENES INVOLVED IN NEURODEVELOPMENT AND IMMUNITY	50
25. EPIGENOME-WIDE META-ANALYSIS OF > 3200 MILITARY AND CIVILIAN PARTICIPANTS IDENTIFIES CELL-TYPE SPECIFIC DNA METHYLATION SIGNALS ASSOCIATED WITH PTSD	48
DIFFERENTIAL ISOFORM USAGE IN SCHIZOPHRENIA	46
W87. RARE, PATHOGENIC COPY NUMBER VARIANTS CO-SEGREGATE WITH SCHIZOPHRENIA IN PEDIGREE COHORT	45
W64. FAMILY BASED ASSOCIATION AND LINKAGE ANALYSES OF FAMILIAL ADHD	45
W101. EPIGENETIC PROFILES OF LATENT CLASSES FOR POLYSUBSTANCE USE DISORDER	44
P.0016 Concomitant drug abuse in patients on methadone maintenance treatment	41
PUMAS: POPULATIONS UNDERREPRESENTED IN MENTAL ILLNESS ASSOCIATION STUDIES PROJECT	40
1. DEVELOPMENTAL TRAJECTORIES OF DNA METHYLATION IN NEURAL CELL POPULATIONS IN HUMAN CORTEX AND LINKS TO NEURODEVELOPMENTAL DISORDERS	39
TU90. STUDY OF GENETIC POLYMORPHISM AND DNA METHYLATION IN TUMOR NECROSIS FACTOR- ALPHA (TNF-Α) AND TRANSMEMBRANE 6 SUPERFAMILY MEMBER 2 (TM6SF2) IN ALCOHOL INDUCED LIVER CIRRHOSIS	37

2. ENRICHMENT OF RARE, DAMAGING VARIANTS IN SCHIZOPHRENIA-RELATED GENES IN INTELLECTUAL DISABILITY PATIENTS WITH PSYCHOTIC DISORDERS	37
W13. CLINICAL VALUE OF DIAGNOSTIC WHOLE GENOME/EXOME SEQUENCING IN FAMILIAL AUTISM SPECTRUM DISORDER	37
Society Calendar	35
ASSESSING THE EFFECTS OF RARE COPY NUMBER VARIANTS ON PSYCHIATRIC SYMPTOMS AND COGNITIVE ABILITY IN ∼1M INDIVIDUALS	35
W14. GENETIC CLUSTERING OF CO-OCCURRING SYMPTOMS IN PEOPLE WITH AUTISM: A MULTIVARIATE GENETIC VARIANCE ANALYSIS OF GENETIC RELATIONSHIP MATRICES IN THE SPARK SAMPLE	35
PHENOME-WIDE GENETIC CORRELATION AND CAUSALITY OF COVID-19 SEVERITY HIGHLIGHTS OVERLAP WITH SUBSTANCE-USE TRAITS	35
6. CONTRIBUTION OF COPY NUMBER VARIANTS TO SCHIZOPHRENIA IN EAST ASIAN POPULATIONS	33
23. MASSIVELY PARALLEL, IN VIVO PROFILING OF MDD SNP EFFECTS ON TRANSCRIPTION ACROSS AGE, SEX, AND CELL TYPE	33
38. LATENT SUBTYPES OF MANIC OR IRRITABLE EPISODE SYMPTOMS IN TWO POPULATION-BASED COHORTS	32
P.0190 Epigenetic mechanisms underlying the stress-induced activation of serum/glucocorticoid regulated kinase 1	32
T70. A COMPUTATIONAL TRANSCRIPTOMICS APPROACH TO DRUG REPURPOSING IDENTIFIES NEW THERAPEUTIC CANDIDATES FOR TREATMENT OF CHRONIC PAIN	31
P.0234 Optogenetic shift of mesolimbic dopamine to tonic pattern reduces reward-seeking behavior	30
P.0235 Selectivity of taar1 partial agonist ro5263397 effects on drug- versus non-drug-related behaviors	30
P.0254 TRPC4/5 inhibition reverses both stress-induced excessive aversion processing and attenuated reward processing in mice	29
P.0247 Assessment of sexual behavior of taar2 and taar5 knockout mice	29
P.0262 Self-directed virtual care: a review of the evidence for current digital therapeutic methods in adult mental health patients	28
P.0260 Optimising a human induced pluripotent stem cell system to model the effects of il-6 on early neurodevelopment	27
P.0320 Depression, anxiety, psychotic-like symptoms and addiction in adolescents and adults who do and do not use cannabis	26
11. ESTABLISHING THE MOLECULAR FOUNDATION OF BRAIN ANATOMY IN LIVING INDIVIDUALS	26
F41. AMBER: ANTIDEPRESSANT MEDICATIONS: BIOLOGY, EXPOSURE AND RESPONSE	25
T84. AN INVESTIGATION ON GENETIC MECHANISMS UNDER CLINICAL HETEROGENEITY IN SCHIZOPHRENIA	25
T56. DIP2A, HIGHLY EXPRESSED GENE IN THE CEREBELLUM, IS ASSOCIATED WITH A WIDE RANGE OF PSYCHIATRIC SYMPTOMS (DELAYED SPEECH, AUTISM SPECTRUM DISORDER AND SPECIFIC LEARNING DISABILITIES)	25
T47. A MULTI-OMIC QTL ANALYSIS OF MAJOR DEPRESSIVE DISORDER	25
T13. GENETIC ASSOCIATIONS OF ICD-DERIVED PSYCHIATRIC DIAGNOSES WITH SELF-REPORTED MENTAL HEALTH PHENOTYPES IN THE UK BIOBANK	24
F8. THE DEVELOPMENTAL LANDSCAPE OF NEUROPSYCHIATRIC GENOMICS IN AFRICA	24
T100. CHILD SUBCORTICAL BRAIN VOLUMES: THE INTERACTION BETWEEN GENETIC RISK AND MATERNAL PSYCHOLOGICAL DISTRESS DURING PREGNANCY	23
F97. DIFFERENTIAL EXPRESSION OF MICRORNAS UPON IN VITRO LITHIUM AND VALPROATE EXPOSURE TO BIPOLAR DISORDER PATIENTS-DERIVED LCLS	23
P.0487 The impact of psychopathy, temperament and character dimensions of personality on crimınal recidivism in patients with schizophrenia	23
T78. GENE-ENVIRONMENT INTERACTION STUDY ON THE CORRELATES FOR PSYCHOTIC EXPERIENCES IN THE UK BIOBANK	23
T59. A GENOME-WIDE ASSOCIATION STUDY OF EATING DISORDER SYMPTOMS BASED ON THE SCOFF QUESTIONNAIRE	21
T35. SHARED GENETIC LIABILITY FOR ALCOHOL CONSUMPTION, ALCOHOL PROBLEMS, AND SUICIDAL BEHAVIOR: EVALUATING THE ROLE OF IMPULSIVITY	21
T8. TREATMENT WITH GALANTAMINE IN 15Q13.3 DELETIONS: GENOMICALLY-INFORMED PRECISION MEDICINE STRATEGIES IN NEURODEVELOPMENTAL DISORDERS	21
T33. USING GENOMICS TO AID EARLY DIFFERENTIAL DIAGNOSIS BETWEEN BIPOLAR DISORDER AND MAJOR DEPRESSION	21
P.0564 Active suicidal ideation one year after the beginning of COVID-19 pandemic in a large spanish sample: risk and protective factors	20
NOVEL LOCI AND TARGET GENES INFLUENCING FUNCTIONAL SEIZURES IDENTIFIED IN A MULTI-SITE GENOME-WIDE ASSOCIATION STUDY META-ANALYSIS IN A SAMPLE OF 570,460 PATIENTS	20
T67. ASSOCIATIONS BETWEEN METHYLATION AGE AND BRAIN AGE IN LATE ADOLESCENCE	20
P.0323 History of abuse and post traumatic stress disorder in patients admitted to an addictive disorders day hospital	20
DO POOR DIET AND LIFESTYLE BEHAVIOURS EXACERBATE THE GENETIC RISK OF IMPULSIVITY IN THE GENERAL POPULATION	20
P.0690 Transdifferentiation of human monocytes into neuronal-like cells in patients with depression	20
P.0325 Corneal endothelial morphology and thickness changes in children with attention-deficit hyperactivity disorder	20
T121. MULTI-OMIC NETWORK ANALYSIS IDENTIFIES KEY NEUROBIOLOGICAL PATHWAYS IN OPIOID ADDICTION	20
P.0426 Proof-of-concept study testing SOM3355 for the treatment of chorea symptoms in Huntington's disease	19
P.0675 Inhibitory control in therapy resistant patients with major depressive disorder	18
P.0669 Differential response to three antidepressants in patients with major depressive episode who suffered Covid-19–related trauma	18
P.0511 The role of sex steroids and serotonin brain dynamics in perinatal mental health	18
DECOLONISATION OF PSYCHIATRIC GENETICS: PERSPECTIVES FROM AN ERSTWHILE “JEWEL IN THE CROWN” COLONY	18
THE ASSOCIATION BETWEEN POLYGENIC RISK FOR SCHIZOPHRENIA AND BRAIN AGE IN A POPULATION-BASED SAMPLE OF YOUNG ADULTS: A RECALL-BY-GENOTYPE-BASED APPROACH	18
POLYGENIC RISK SCORES FOR PROBLEMATIC SUBSTANCE USE IN ADOLESCENTS: AN ENIGMA-ADDICTION STUDY	18
P.0663 Zebrafish model : study of KCNB1 in developmental and epileptic encephalopathies	17
P.0665 Reward processing differences between Obsessive-compulsive disorder and pathological gambling	17

P.0632 The added value of cognitive behavioral therapy on quality of life in combination with pharmacotherapy in adults with ADHD	17
P.0697 Exposure to an enriched environment shortens the onset of venlafaxine response which correlate with the remodeling of hippocampal parvalbumin interneurons	17
P.0565 Calcium salt of N-(5-hydroxynicotinoyl)-L-glutamic acid weakens depressive-like behavior and Parkinsonian syndrome in experiment on rodents	17
A specific GPR56/ADGRG1 splicing isoform is associated with antidepressant response in major depressive disorder	16
P.0735 Functional impacts function - beyond organic symptoms in autoimmune encephalitis	16
ECNP Calendar of Meetings	16
Sodium nitroprusside enhances the antipsychotic-like effect of olanzapine but not clozapine in the conditioned avoidance response test in rats	16
Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review	16
P.0705 Antidepressant response prediction by early response, prefrontal theta cordance in rapid-eye movement sleep and ABCB1 genotype	16
The effects of transient receptor potential cation channel inhibition by BI 1358894 on cortico-limbic brain reactivity to negative emotional stimuli in major depressive disorder	16
Editorial Board	16
P.0753 Pharmacotherapy, treatment satisfaction and funcional impact among fibromyalgia patients: characterization of a Portuguese sample	16
Opioid use and misuse in Europe: COVID-19 new challenges?	16
The future of antipsychotics studies: How innovative designs may benefit patients with psychotic disorders	15
P.0224 Dosing regimen overview of treatment-resistant depression patients treated with esketamine: eskale study interim analysis	15
Norepinephrine system dysconnectivity in major depressive disorder: the effect of short term SSRI treatment	15
Regarding the meta-analyses of pharmacogenomics-guided antidepressant treatment: A response to Milosavljevic et al.	15
Exploring the link between functional connectivity of ventral tegmental area and physical fitness in schizophrenia and healthy controls	15
Co-exposure of cocaine and cannabinoids and its association with select biological, behavioural and health outcomes: A systematic scoping review of multi-disciplinary studies	15
Clinical and psychopathological correlates of duration of untreated illness (DUI) in affective spectrum disorders	15
Comparative effectiveness of mood stabilizers and antipsychotics in the prevention of hospitalization after lithium discontinuation in bipolar disorder	15
No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial	15
Muscle and the mind: The combination of creatine and exercise for depression	15
The association of CNR1 genetic variants with resting-state functional connectivity in youth bipolar disorder	15
Prader Willi syndrome, its psychiatric implications and their possible biological basis	14
As in cooking, so in medicine: Doses do matter	14
F93. CELL-TYPE SPECIFIC TRANSCRIPTOMIC PROFILING IN SCHIZOPHRENIA IDENTIFIES CHANGES IN GABAERGIC NEURONS AND OLIGODENDROCYTES AT TRANSCRIPT LEVEL	14
Letter to editor about the article “Clinical features in co-occuring obsessive-compulsive disorder and bipolar disorder: A systematic review and meta-analysis” (De Prisco M et al.,2023)	14
Associations between individual depressive symptoms and immunometabolic characteristics in major depression	14
Neuroimaging revealed long-lasting glucose metabolism changes to morphine withdrawal in rats pretreated with the cannabinoid agonist CP-55,940 during periadolescence	14
Pediatric Bipolar Disorder – Misinformation with Unintended Negative Consequences for Children and Adolescents	14
Exploring the relationship between the gut microbiome and mental health outcomes in a posttraumatic stress disorder cohort relative to trauma-exposed controls	14
Psychopathology for the twenty-first century: Towards a ChatGPT psychopathology?	14
Number needed to treat and number needed to harm: What are they good for?	13
46. PATHWAY-BASED POLYGENIC RISK SCORES USING MACHINE LEARNING: APPLICATION TO SCHIZOPHRENIA AND BIPOLAR DISORDER	13
P.0075 Sex differences in anxiolytic and antidepressant response following subacute drug treatment: the effect of the oestrous cycle	13
TH60. POLYGENIC MODELS OF COMORBIDITY AND PLEIOTROPY IN PSYCHIATRY IN A HIGHLY COMORBID COHORT	13
54. EXAMINING COMMON AND SPECIFIC GENETIC INFLUENCES ON SCHIZOPHRENIA, BIPOLAR DISORDER, AND DEPRESSION	13
P.0059 Self-reported suicide attempts in the general population and association with alcohol consumption in Latvia in 2010-2018	13
TH82. NOVEL DISEASE ASSOCIATIONS WITH SCHIZOPHRENIA GENETIC RISK REVEALED IN ∼400,000 UK BIOBANK PARTICIPANTS	13
P.0062 Role of stress history in the development of a depressive-like phenotype in elderly in rats exposed to repeated social defeat	13
W97. A GENOMEWIDE ASSOCIATION STUDY OF ANTIPSYCHOTIC INDUCED EXTRAPYRAMIDAL SIDE EFFECTS	12
W5. NUTRITIONAL BIOMARKERS IN PREGNANCY AND NEURODEVELOPMENTAL OUTCOMES IN OFFSPRING – A MENDELIAN RANDOMIZATION STUDY IN THE NORWEGIAN MOTHER, FATHER AND CHILD COHORT STUDY (MOBA)	12
TU83. COMPARING GENE EXPRESSION CHANGES IN BLOOD AND BRAIN OF SCHIZOPHRENIA	12
W79. METHYLATION AND BRAIN STRUCTURE IN SCHIZOPHRENIA: ANALYSIS OF THE ROLE OF COMT AND BDNF GENES	12
P.0112 Evaluation of circadian rhythm parameters and NR1D1 single nucleotide polymorphism relationship to predict lithium response in bipolar disorder	12
PRS PREDICTION BEYOND FAMILY HISTORY	12
MULTI-ANCESTRY GENOME-WIDE ASSOCIATION STUDIES PROVIDE NOVEL BIOLOGICAL INSIGHTS INTO THE GENETIC ARCHITECTURE OF BIPOLAR DISORDER	12
EVALUATING THE CAUSAL RELATIONSHIP BETWEEN EDUCATIONAL ATTAINMENT AND MENTAL HEALTH	12
P.0126 Involvement of the snare complex SNAP-25 and stx1a polymorphisms in sarcopenia	12
W31. USING NEURAL NETWORKS TO CREATE A POLYGENIC RISK SCORE OF MAJOR DEPRESSIVE DISORDER	12
POLYGENIC SCORE OF POST-TRAUMATIC STRESS DISORDER HIGHLIGHTS ASSOCIATION WITH CARDIOVASCULAR DISORDERS IN ELECTRONIC HEALTH RECORDS OF >94,000 INDIVIDUALS	12
W40. MEASURING 100 PERSONALITY TRAITS AND 9 COGNITIVE DOMAINS AT BIOBANK SCALE UNDER 1 HOUR – OPPORTUNITIES FOR PSYCHIATRIC GENOMICS	12
TH4. A CAUSAL ROLE FOR ATTENTION DEFICIT/ HYPERACTIVITY DISORDER ON RISK-TAKING BEHAVIOURS, ACADEMIC AND FINANCIAL PROBLEMS AND MAJOR DEPRESSION	11
ECNP Calendar of Meetings	11
F3. METABOLIC EFFECT OF CYP2C19 AND CYP2D6 ON ANTIDEPRESSANT RESPONSE: A META-ANALYSIS OF 13 DEPRESSION PHARMACOGENETIC STUDIES	11
73. IMPACT OF GENETIC RISK VARIANTS OF MENTAL DISORDERS ON EPIGENETIC REGULATION: AN MQTL APPROACH	11
PRESENTING A MULTIDISCIPLINARY FRAMEWORK FOR RESEARCH GENOME SEQUENCING COUPLED WITH GENETIC COUNSELING AND RETURN OF CLINICALLY VALIDATED PRIMARY AND SECONDARY FINDINGS FOR INDIVIDUALS WITH PSYCHIATR	11
ASSESSING THE UTILITY OF PHARMACOGENETIC TESTING IN A COHORT WITH TREATMENT-RESISTANT SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER	11
P.0747 The CD45+ blood cells alpha-synuclein concentration in synucleinopathies	11
P.0278 Structural brain abnormalities associated with cognitive impairments in bipolar disorder	11
GENOMIC STRUCTURAL EQUATION MODELING APPLIED TO 14 MAJOR PSYCHIATRIC DISORDERS	11
TREML2 IN THE CONTEXT OF WHITE MATTER HYPERINTENSITIES AND ALZHEIMER'S DISEASE	11
P.0713 Effectiveness and safety of vortioxetine in real-world clinical practice in China: results from the prospective RELIEVE China study	11
P.0798 Acute peritraumatic distress predicts post-traumatic stress disorder at 6 months in patients with bipolar disorder followed during the COVID-19 pandemic	11
86. AN INTERNATIONAL, CASE-CASE MEGA-ANALYSIS OF TREATMENT-RESISTANT SCHIZOPHRENIA VERSUS NON-TREATMENT RESISTANT SCHIZOPHRENIA	11
32. PRINCIPAL AND INDEPENDENT GENOMIC COMPONENTS OF BRAIN STRUCTURE AND FUNCTION: ROBUSTNESS AND RELEVANCE	11
W44. UNVEILING GENETIC ARCHITECTURES FOR STRATIFYING TRAJECTORIES OF ADOLESCENT DEPRESSION	10
28. ESTIMATING THE GENETIC RELATIONSHIP BETWEEN PSYCHIATRIC DISORDERS AND CARDIOMETABOLIC TRAITS ASSESSED IN A SINGLE NATIONAL COHORT REPRESENTING DENMARK USING MULTIPLE METHODS	10
W14. EXPLORING THE RELATIONSHIP BETWEEN GENETIC PREDISPOSITION TO MENTAL HEALTH DISORDERS AND THE SOCIAL ENVIRONMENT IN THE UK BIOBANK	10
PHARMACOGENETICS OF ANXIETY AND OBSESSIVE-COMPULSIVE DISORDERS	10
P.0182 Cytomegalovirus infection and IQ in adolescents with early-onset psychosis	10
WHOLE EXOME SEQUENCING IN AN AUTISM MULTIPLEX FAMILY OF INDIAN ORIGIN REVEALS INCREASED GENETIC BURDEN OF MATERNALLY TRANSMITTED VARIANTS	10
GENETIC CHARACTERIZATION OF NEURODEVELOPMENTAL DISORDERS IN AFRICAN POPULATIONS: THE NEURODEV TRIO PILOT	10
47. GENE DISCOVERY FROM EXOME SEQUENCING IN AUTISM AND COMPARISON TO DEVELOPMENTAL DELAY AND SCHIZOPHRENIA	10
W35. INVESTIGATION OF RELATIONSHIPS BETWEEN INTERNALIZING, EXTERNALIZING, AND RISKY SEXUAL BEHAVIOR: A GENETICALLY-INFORMATIVE SAMPLE	10
TU46. ASSOCIATION OF THE RS1031381 POLYMORPHIC VARIANT IN THE NCAPD3 GENE WITH PSYCHODIAGNOSTIC TRAITS (16 PF CATTELL'S QUESTIONNAIRE) IN RUSSIAN STUDENTS	10
T65. GENES IN POSTMORTEM BRAIN TISSUE DIFFERENTIALLY EXPRESSED IN CHRONIC PAIN	10
P.0631 Functional connectivity of basal ganglia nuclei in ADHD and pharmacologically challenged healthy volunteers with a genetic risk profile	10
21. DISSECTING THE PRENATAL ORIGINS OF PSYCHIATRIC DISORDERS USING SEX-BIASED MQTL IN THE PLACENTA	10

W6. INTERACTION BETWEEN BDNF METHYLATION, SUICIDAL IDEATION, AND LONG-TERM OUTCOMES AFTER STROKE	10
55. MULTI-MODAL EVIDENCE THAT PANDEMIC INFLUENZA INFLUENCES SCHIZOPHRENIA RISK	10
P.0172 Deciphering the role of MIR-137 targetome in schizophrenia: temporal profiling and comorbidity with psychiatric disorders	10
T95. ITERATING TOWARDS PRECISION PHENOTYPING OF SCHIZOPHRENIA IN THE ELECTRONIC HEALTH RECORD	10
TU30. THE INTERACTION BETWEEN POLYGENIC LIABILITY AND VARYING STRESS LEVELS IN THE DEVELOPMENT OF MAJOR DEPRESSION: A LIFELINES COVID-19 PANDEMIC STUDY	10
T71. GENETIC AND ENVIRONMENTAL ASSOCIATION BETWEEN PRESENT MOMENT ATTENTION AND SUBJECTIVE WELLBEING	9
W38. INVESTIGATION OF GENE-ENVIRONMENT INTERACTIONS BETWEEN GENETICALLY REGULATED GLUCOCORTICOID REACTIVITY AND STRESSFUL LIFE EVENTS IN MAJOR DEPRESSIVE DISORDER	9
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment and self-reported side effects in the euthymic phase of bipolar disorders: Results from the FACE-BD coh	9
P.0374 Use of cariprazine in first episode mania: the importance of the treat and the treatment	9
P.0528 Long-acting antipsychotic injectables in patients under compulsory outpatient treatment: the right to choose	9
DECODING CELL TYPE-SPECIFICITY THROUGH SYSTEMATIC CELL TYPE ANNOTATIONS OF SINGLE-CELL RNA SEQUENCING DATA AMONG TISSUES AND APPLICATION TO PSYCHIATRIC DISORDERS AND OTHER TRAITS	9
P.0477 Antipsychotic treatment and risk of discontinuation of cardiometabolic drugs in schizophrenia	9
Editorial Board	9
T75. ASSOCIATIONS BETWEEN POLYGENIC RISK SCORE FOR SCHIZOPHRENIA AND SCHIZOTYPAL TRAITS IN THE MULTIPLEX FAMILIES OF PATIENTS WITH SCHIZOPHRENIA	9
F11. PATTERNS OF GENETIC OVERLAP BETWEEN BIPOLAR DISORDER, SUBSTANCE USE DISORDERS AND SUBSTANCE CONSUMPTION PHENOTYPES REVEAL DISTINCT FACTORS OF PATHOLOGY	9
Corrigendum to “Modelling decision-making under uncertainty: A direct comparison study between human and mouse gambling data” [31, February 2020, Pages 58–68]	9
P.0673 Specificity of neurocognitive impairment in patients with schizophrenia and endogenous depression	9
P.0522 Accessing electroconvulsive therapy: description and factors associated with variation of utilization in france in 2019	9
P.0364 Neurocognitive profiles of bipolar disorder patients receiving olanzapine or quetiapine in addition to mood-stabilizers	9
P.0365 Associations between abnormal brain function during emotion processing and lifetime disease course in major depressive disorder	9
T68. DDR1 PROMOTER METHYLATION IN DIFFERENT PSYCHIATRIC DISORDERS AND ITS RELATIONSHIP TO NEUTROPHIL-TO-LYMPHOCYTE RATIOS	9
P.0393 Interoception sensitivity and social ineraction in major depressive episode	9
T3. DEPRESSION ASSOCIATED GENETIC, TRANSCRIPTOMIC AND PATHWAY -LEVEL PROFILING OF TRAUMA-EXPOSED MILITARY AND CIVILIAN COHORTS	9
W32. A GENOME-WIDE ASSOCIATION STUDY OF BIPOLAR DISORDER FROM INDIA	9
W31. KETAMINE AND ELECTROCONVULSIVE THERAPY DEPRESSION TREATMENTS ALTER ISOFORM- AND CELL TYPE-SPECIFIC TRANSCRIPTOMES IN THE MOUSE PREFRONTAL FRONTAL CORTEX	9
EXOME SEQUENCING TECHNOLOGY AND ANALYSIS	9
P.0438 Saccadik eye movements in simple and complex visual environments differenciate mild cognitive impairment: preliminary clinical results	9
T23. ASSOCIATION OF CHILDHOOD TRAUMA EXPOSURE WITH DDR1 PROMOTER METHYLATION IN BIPOLAR DISORDER	9
P.0358 Synergistic anticonvulsant effect of carbamazepine and mono-/bicyclic terpenoids on pentylenetetrazole-induced seizures	9
Editorial Board	9
Social Stress in Bipolar Disorder	8
A randomised, placebo-controlled, double blind, crossover trial on the effect of a 20:1 cannabidiol: Δ9-tetrahydrocannabinol medical cannabis product on neurocognition, attention, and mood	8
F99. GENETIC CORRELATION OF CHILDHOOD AGGRESSION WITH MENTAL AND GENERAL HEALTH TRAITS	8
W17. REGIONAL GENETIC ARCHITECTURE OF THE CORPUS CALLOSUM AND ITS OVERLAP WITH PSYCHIATRIC AND SUBSTANCE USE PHENOTYPES	8
INNOVATING KNOWLEDGE DISSEMINATION FOR CULTURAL RELEVANCE AND ACCESSIBILITY	8
W9. IDENTIFYING CENTRAL AND TRANS-DIAGNOSTIC PSYCHIATRIC SYMPTOMS COMBINING NETWORK ANALYSIS AND GENETICS	8
Current level of evidence for improvement of antidepressant efficacy and tolerability by pharmacogenomic-guided treatment: A Systematic review and meta-analysis of randomized controlled clinical trial	8
Letter to the editor concerning: “Antipsychotic drug dosing and study discontinuation in schizophrenia: A systematic review and dose-response meta-analysis”	8
F10. TRACES OF ASSORTATIVE MATING FOR MENTAL DISORDERS IN THE HUMAN GENOME	8
ABSENCE OF NONFATAL SUICIDAL BEHAVIOR PRECEDING SUICIDE DEATH REVEALS CLINICAL AND GENETIC RISK DIFFERENCES	8
87. RS148582811 REGULATES ITS HOST GENE ARVCF EXPRESSION TO AFFECT NICOTINE-ASSOCIATED HIPPOCAMPUS-DEPENDENT MEMORY	8
BEYOND BORDERS: INTEGRATING TRAINING AND RESEARCH FOR SCIENTIFIC EXCELLENCE AND GLOBAL EQUITY	8
Prescription sequences in bipolar disorder – A nationwide Danish register-based study of 19,927 individuals followed for 10 years	8
Serotonin 5-HT2A receptors in schizophrenia: Reflexions on an unfinished story	8
20. PHENOME-WIDE ASSOCIATION STUDY OF COGNITIVE FUNCTION IN MULTIETHNIC ASIAN POPULATION	8
F59. DISENTANGLING THE OVERLAP BETWEEN SUICIDE ATTEMPT AND ASSOCIATED PHENOTYPES USING LOCAL GENETIC CORRELATIONS	8
LONGITUDINAL GENETIC APPROACHES IN MENTAL HEALTH: INTERNATIONAL PERSPECTIVES AND OPPORTUNITIES	8
75. GWAS IDENTIFIES NOVEL LOCI ASSOCIATED WITH SPECIFIERS OF BIPOLAR DISORDER	8
Clinician- versus caregiver-rated scales as outcome measures of repetitive-restricted behaviors in clinical trials of autism: A systematic review and meta-analysis	7
Exploring the incidence of inadequate response to antidepressants in the primary care of depression	7
F57. INVESTIGATION OF THE SEX CHROMOSOMES IN AUTISM SPECTRUM DISORDER	7
81. PATTERNS OF BRAIN ASYMMETRY ASSOCIATED WITH POLYGENIC RISKS FOR AUTISM AND SCHIZOPHRENIA IMPLICATE LANGUAGE AND EXECUTIVE FUNCTIONS BUT NOT BRAIN MASCULINIZATION	7
49. INTEGRATION OF TRANSCRIPTOMIC AND PROTEOMIC DATA TO REFINE POLYGENIC-RISK INFORMED DRUG REPURPOSING CANDIDATES FOR PSYCHOSIS	7
DELETERIOUS “SHIFT” IN FUNCTIONAL PERFORMANCE EXPLAINS CLINICAL VARIABILITY IN RARE GENETIC NEURODEVELOPMENTAL PSYCHIATRIC DISORDERS	7
F80. A DNA METHYLATION STUDY OF COMMON AND SPECIFIC TREATMENT EFFECTS OF THREE ANTIPSYCHOTICS IN THE TREATMENT OF PSYCHOSIS	7
Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases	7
P.0309 The effect of dihydromyricetin (dhm) from hovenia dulcis extract on alcohol hangover severity	7
How else can inflammation kill you?	7
There are no patients without comorbidity	7
Effects of quetiapine on sleep: A systematic review and meta-analysis of clinical trials	7
F59. DISSECTING THE CONTRIBUTIONS OF RARE AND COMMON GENETIC VARIATION TO NEURODEVELOPMENTAL OUTCOMES	7
20. CHROMATIN ACCESSIBILITY MAPPING REVEALS COMPOUND GENETIC EFFECTS AT A SCHIZOPHRENIA GWAS RISK LOCUS IMPAIRING NEURODEVELOPMENT AND SYNAPTIC FUNCTION IN HUMAN NEURONS	7
Assessing risk for bipolar disorder. Comments on ``Young people at risk for developing bipolar disorder: Two-year findings from the multicenter prospective, naturalistic Early-BipoLife study'' (Martin	7
14. PROFILING NEUROEPIGENOMIC NETWORKS OF OPIOID USE DISORDER IN HUMAN ORBITOFRONTAL CORTEX	7
Orbitofrontal cortex hypergyrification in hallucinating schizophrenia patients: Surface ratio as a promising brain biomarker	7
The effects of acute dopamine depletion on resting-state functional connectivity in healthy humans	7
Diabetes complication burden and patterns and risk of mortality in people with schizophrenia and diabetes: A population-based cohort study with 16-year follow-up	7
Disease continuum centered on Parkinson's disease	7
F73. CLINICAL AND GENETIC TRAUMA-RELATED RISK FACTORS LEADING TO SUICIDE DEATH	7
63. LEVERAGING GWAS FOR INSOMNIA TO IDENTIFY NOVEL REGULATORS OF SLEEP	7
73. ACCOUNTING FOR FAMILY HISTORY AND AGE OF ONSET IMPROVES POWER IN GENOME-WIDE ASSOCIATION STUDIES	7
FINE-MAPPING ACROSS DIVERSE ANCESTRIES DRIVES THE DISCOVERY OF PUTATIVE CAUSAL VARIANTS UNDERLYING HUMAN COMPLEX TRAITS AND DISEASES	7
Antidepressant efficacy of cariprazine in bipolar disorder and the role of its pharmacodynamic properties: A hypothesis based on data	7
P.0173 Cannabinoid receptor genes, cannabis use and brain activity in first-episode psychosis	6
93. DEVELOPING A PHENOTYPE RISK SCORE FOR TIC DISORDERS IN A LARGE CLINICAL BIOBANK	6
26. UNRAVELING THE HETEROGENEITY OF PTSD SYMPTOMS THROUGH IDENTIFYING EPIGENETIC SUBTYPES AMONG TRAUMA-EXPOSED CIVILIAN WOMEN	6
GENOME-WIDE GENE-GENE INTERACTION OF THE 5-HTTLPR PROMOTER POLYMORPHISM EMPHASIZES THE IMPORTANT ROLE OF NEUROPLASTICITY IN DEPRESSION	6
F44. DIFFERENCES IN POLYGENIC RISK SCORE FOR MAJOR DEPRESSIVE DISORDER DEPENDING ON CASE DEFINITION IN AN ELECTRONIC HEALTH RECORDS STUDY	6
GENOME-WIDE ASSOCIATION STUDIES OF ANOREXIA NERVOSA: AN OVERVIEW, UPDATE, AND IMPLICATIONS	6
CONTRIBUTION OF GENOME SEQUENCING IN THE EVALUATION OF CHILDREN AND ADOLESCENTS WITH SUSPECTED SERONEGATIVE AUTOIMMUNE ENCEPHALITIS	6
W85. EVALUATION OF THE PSYCHOMETRIC PROPERTIES OF THE UBACC QUESTIONNAIRE IN ASSESSING CAPACITY TO CONSENT IN DIVERSE AFRICAN POPULATIONS	6
ECNP Calendar of Meetings	6
57. TRANSCRIPTOMIC DYSFUNCTION DISPARITIES: GREATER BURDEN IN FEMALE BRAINS HIGHLIGHTS IMMUNE AND SYNAPTIC PATHWAYS FOR PSYCHIATRIC DISORDERS	6
EXPANDING OUR UNDERSTANDING OF GENETIC RISK FOR BINGE EATING VIA A GENOME-WIDE ASSOCIATION STUDY	6
F39. CONTRIBUTION OF COMMON POLYGENIC VARIATION TO THERAPY RESPONSE IN THE EARLY MEDICATION CHANGE COHORT	6
PHARMACOGENETIC INFORMED PRESCRIBING FOR MAJOR DEPRESSIVE DISORDER	6
INTEGRATING POLYGENIC RISK SCORES WITHIN TWIN MODELLING TO INVESTIGATE THE CAUSAL RISK FACTORS FOR SELF-HARM	6
P.0114 Complement factor C4 and phenotypes in bipolar disorder	6
95. PSYCHIATRIC GENETIC COUNSELING IS ASSOCIATED WITH A DECREASE IN PSYCHIATRIC HOSPITALIZATION	6
T56. NEONATAL BLOOD TRANSCRIPTOMICS REVEAL EXPRESSION SIGNATURES OF ADHD RISK	6
PERCEPTIONS OF CAUSAL ATTRIBUTION AND ATTITUDES TO GENETIC TESTING AMONG PEOPLE WITH SCHIZOPHRENIA AND THEIR FIRST-DEGREE RELATIVES	6
HOW DO WE MAKE POLYGENIC RISK SCORES (PRS) UNDERSTANDABLE? THE DEVELOPMENT AND EVALUATION OF A NEW TOOL TO ACCOMPANY PRS	6
P.0274 Effect of BDNF polymorphism and dna methylation on reward learning and cognitive performance in major depression	6
W23. GENOME-WIDE ASSOCIATION STUDY OF UNCONTROLLED EATING	6
TU79. NEUROANATOMICAL AND GENETIC CORRELATES OF FACIAL SHAPE: POTENTIAL BIOMARKERS FOR SCHIZOPHRENIA	6